Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Non-Current Assets: 2019-2023

Historic Non-Current Assets for ADC Therapeutics (ADCT) over the last 3 years, with Sep 2023 value amounting to $91.3 million.

  • ADC Therapeutics' Non-Current Assets fell 2.52% to $91.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $91.3 million, marking a year-over-year decrease of 2.52%. This contributed to the annual value of $83.2 million for FY2022, which is 10.39% down from last year.
  • ADC Therapeutics' Non-Current Assets amounted to $91.3 million in Q3 2023, which was down 3.38% from $94.5 million recorded in Q2 2023.
  • Over the past 5 years, ADC Therapeutics' Non-Current Assets peaked at $96.0 million during Q2 2022, and registered a low of $14,717 during Q2 2020.
  • Moreover, its 3-year median value for Non-Current Assets was $91.3 million (2023), whereas its average is $85.6 million.
  • As far as peak fluctuations go, ADC Therapeutics' Non-Current Assets spiked by 475,227.85% in 2021, and later decreased by 10.39% in 2022.
  • Quarterly analysis of 5 years shows ADC Therapeutics' Non-Current Assets stood at $15.1 million in 2019, then reached $15,107 in 2020, then skyrocketed by 460,421.61% to $92.8 million in 2021, then decreased by 10.39% to $83.2 million in 2022, then decreased by 2.52% to $91.3 million in 2023.
  • Its last three reported values are $91.3 million in Q3 2023, $94.5 million for Q2 2023, and $87.7 million during Q1 2023.